Virus‐like particles for vaccination against cancer-Reference-Cited by-同舟云学术

Virus‐like particles for vaccination against cancer

Published:2019-08-27 Issue:1 Volume:12 Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Mohsen Mona O.¹²^ORCID,Speiser Daniel E.³,Knuth Alexander¹,Bachmann Martin F.²⁴

Affiliation:

1. The Interim Translational Research Institute “iTRI” National Center for Cancer Care & Research (NCCCR) Doha Qatar

2. Department of BioMedical Research, Immunology RIA University of Bern Bern Switzerland

3. Department of Oncology University of Lausanne Lausanne Switzerland

4. Nuffield Department of Medicine, Jenner Institute University of Oxford Oxford UK

Funder

Krebsforschung Schweiz

Qatar National Research Fund

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1579

Reference114 articles.

1. American Association for Cancer Research Annual Meeting. (2018). Intratumoral toll‐like receptor 9 (TLR9) agonist CMP‐001 in combination with pembrolizumab can reverse resistance to PD‐1 inhibition in a phase Ib trial in subjects with advanced melanoma. Retrieved fromhttp://www.abstractsonline.com/pp8/#!/4562/presentation/11133

2. Expression and purification of virus‐like particles for vaccination;Arevalo M. T.;Journal of Visualized Experiments,2016

3. Role of antibodies in cancer targeting

4. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

5. Therapeutic vaccines for chronic diseases: successes and technical challenges

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-Assembly of Polymers and Their Applications in the Fields of Biomedicine and Materials;Polymers;2024-07-23

2. Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response;Vaccines;2024-06-14

3. Recombinant VLP Vaccines Synthesized in Plant Expression Systems: Current Updates and Prospects;Molecular Biology;2024-06

4. Unlocking the Role of Virus-like Particles (VLPs) for Cancer Treatment;Current Cancer Therapy Reviews;2024-05-23

5. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy;Frontiers in Immunology;2024-03-12